Welcome to Biotech Spotlight, where we talk about companies making big strides in technology and medicine. Today, we’re focusing on Imunon, a company that might have found a new way to treat ovarian cancer, something we haven’t seen in a long time. Let’s hear from Stacy Lindborg, the CEO of Imunon. Imunon’s Goal: Imunon is working on a way to teach our immune system to fight diseases like cancer. They use a special method that doesn’t involve viruses. Their main tool, called TheraPlas, is designed to help the immune system fight cancer. They’re starting with ovarian cancer, which is hard to treat. Their leading treatment, IMNN-001, is in the final stage of testing for women who have just been diagnosed with ovarian cancer. It works by giving the body instructions to make a substance that helps the immune system fight cancer. They’re also testing a vaccine for COVID-19 and other diseases. Imunon used to be called Celsion Corporation, but they changed their name in 2022 to show their focus on fighting cancer with the immune system. Why This Matters: There have been some improvements in treating ovarian cancer, but not for the first treatments that doctors use. These first treatments often involve strong medicines that can make people very sick. Stacy Lindborg says that other new treatments haven’t worked as well as hoped. But IMNN-001 might be different. It could be the first new treatment for ovarian cancer in almost 30 years. In tests, it has helped people live longer. IMNN-001 is different because it doesn’t give the body the substance directly. Instead, it gives the body instructions to make the substance itself. This means it can work better and cause fewer side effects. What’s Next: Imunon is doing more tests on IMNN-001 for ovarian cancer. They’re also looking into using it for other types of cancer, like stomach, pancreatic, and liver cancer. They hope to work with other companies to make these treatments available to everyone who needs them. In short, Imunon is giving us hope for a better way to treat ovarian cancer and other diseases.